BSE filing, NSE: AKUMS. Summary written from the filing by ALFA Finder's alert engine.
Akums Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹731.70
- Market cap
- ₹11,517 Cr
- Revenue (annual)
- ₹4,359 Cr
- Net profit (annual)
- ₹255.2 Cr
- P/E (TTM)
- 39.5×Sector 45.9×
- Promoter holding
- 75.26%+0.00% QoQ
- FII holding
- 4.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akums Drugs & Pharmaceuticals Ltd
All →Akums Drugs & Pharmaceuticals Board Meeting Date
Akums Drugs intimated that its Board meeting is scheduled for 2 November 2026 to consider un-audited Q1 and H1 FY27 results. No financial figures or decisions have been announced yet.
Akums Drugs & Pharmaceuticals Legal & Regulatory
Akums Drugs and Pharmaceuticals received a ₹52.75 Crore NPPA demand notice. The company claims no liability, citing an indemnity agreement with its marketer.
- Value
- ₹52.75 Cr
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing notes the removal of two entities from the promoter group.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals received an ESG rating of 65 for FY2025-26 from NSE Sustainability Ratings & Analytics Limited. The rating was assigned voluntarily based on publicly available information.
Akums Drugs & Pharmaceuticals Other Announcement
Akums Drugs and Pharmaceuticals Limited has cancelled its participation in the Antique Healthcare Investor Conference scheduled for August 25, 2026, due to unavoidable medical reasons.
Akums Drugs & Pharmaceuticals Earnings Call Transcript: Key Takeaways
Akums reported strong Q1FY27 performance with 13.9% revenue growth and 56.1% PAT increase. Results were driven by a robust 18.6% growth in the CDMO segment and improved API pricing.
Other board meeting date announcements
All →Bajaj Steel Industries Board Meeting Date
Bajaj Steel will hold a board meeting on 6 November 2026 to approve unaudited quarterly and half-year results. The trading window stays closed.
Aashka Hospitals Board Meeting Date
Aashka Hospitals Ltd informed BSE of a board meeting on 05 November 2026 to consider unaudited standalone financial results for the half year ended September 30, 2026. The filing is a routine board meeting intimation.
ECS Biztech Board Meeting Date
ECS Biztech schedules a 4 November 2026 board meeting to approve September 2026 quarter and half-year standalone results. Trading window stays closed until 48 hours post-results.
Orchasp Board Meeting Date
Orchasp will hold a board meeting on November 11, 2026 to approve unaudited half-yearly results. The trading window stays closed until November 13, 2026.
Vintage Securities Board Meeting Date
Vintage Securities will hold a board meeting on 05 November 2026 to consider unaudited standalone half-yearly results for September 2026. The meeting date is advance notice and the trading window closes from 01 October 2026.
SVP Global Textiles Board Meeting Date
SVP Global Textiles schedules a 9 November 2026 board meeting to consider September 2026 quarter results. Trading window stays closed until 48 hours after results.